|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | PPAR-alpha activation protects the type2diabetic myocardium against ischemia-reperfusion injury:involve-ment of the PI3-Kinase/Akt and NO pathway显示文摘 | Bulhak A A Jung C Ostenson C G | 2009 | Am J Physiol Heart Circ Physiol2009，296，3： | 1 |
| 2 | PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia -reperfusion injury, involvement of the PI3 -Kinase/Akt and NO pathway 显示文摘 | Bulhak AA Jung C Ostenson CG | 2009 | Am J Physiol Heart Circ Physiol2009，296，3： | 1 |
| 3 | PPAR-activation protects the Type 2 diabetic myocardium against ischemia-reperfusion injury:involvement of the PI3-Kinase/Akt and NO pathway显示文摘 | Bulhak AA Jung C Ostenson CG | 2009 | Am J Physiol Heart Circ Physiol2009，296，3： | 1 |
| 4 | Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation显示文摘 | Bulhak A Roy J Hedin U | 2007 | American Journal of Physiology-heart and Circulatory Physiology2007，292，6： | 1 |
| 5 | PPAR-α activa- tion protects the type 2 diabetic myocardium against is- chemia-reperfusion injury:involvement of the PI3-Kinase/ Akt and NO pathway显示文摘 | Bulhak AA Jung C Ostenson CG | 2009 | Physiol Heart Circ Physiol2009，296，3： | 1 |
| 6 | Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase,Akt,and nitric oxide 显示文摘 | Gonon AT Widegren U Bulhak A | 2008 | Cardiovasc Res2008，78，1： | 1 |
| 7 | PPAR-alpha activation pro- tects the type 2 diabetic myocardium against ischemia-reperfusion in- jury: involvement of the PI3-Kinase/Akt and NO pathway 显示文摘 | Bulhak AA Jung C Ostenson CG | 2009 | Am J Physiol Heart Circ Physiol2009，296，3： | 1 |
| 8 | PPAR-alpha activation protects the type 2 diabetic myocardium against iscbemia-repeffusion injury: involvement of the PB-Kinase/Akt and NO pathway 显示文摘 | BULHAK A A JUNG C OSTENSON C G | 2009 | Am J Physiol Heart Ciro PhysioI2009，296，3： | 1 |
| 9 | Adiponectin protects against my- cardial ischaemia-reperfusion injury via AMP-activated protein kinase,Akt, and nitric oxide 显示文摘 | Gonon AT Widegren U Bulhak A | 2008 | Cardiovasc Res2008，78，1： | 1 |
| 10 | Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide 显示文摘 | Gonon AT Widegren U Bulhak A | 2008 | Cardiovasc Res2008，78，1： | 1 |
| 11 | Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level显示文摘 | Bulhak AA Gourine AV Gonon AT | 2005 | Acta Physiol Scand2005，183，2： | 1 |
| 12 | Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase,Akt,and nitric oxide显示文摘 | Gonon AT Widegren U Bulhak A | | 0，，01： | 1 |
| 13 | Adlponectin protects against myo- eardlul iachaemia-repeffusiou injury via AMP-activated protein Idanse, Akt, and nitric oxide显示文摘 | Gonon AT Widegren U Bulhak A | 2008 | Cardiovaac Res2008，78，1： | 1 |
| 14 | Cardioproteetion mediated by rosiglitazone, a peroxisome proliferator-aetivated receptor gamma ligand, in relation to nitric oxide显示文摘 | Gonon AT Bulhak A Labruto F | 2007 | Basic Res Cardiol2007，102，1： | 1 |
| 15 | Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation 显示文摘 | Bulhak A Roy J Hedin U | 2007 | Am J Physiol Heart Circ Physiol2007，292，： | 1 |
| 16 | Adiponectin protects agains myo- cardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide显示文摘 | Gonon AT Widegren U Bulhak A | 2008 | Cardiovasc Res2008，78，1： | 1 |
| 17 | Rosuvastatin protects themyocardium against ischemia-reperfusion injury via inhibition of GGPP synthesis显示文摘 | Bulhak A Sjoquist PO Pernow J | 2004 | Cardiovasc J S Afr2004，15，41： | 1 |
| 18 | Cardioprotection mediated by rosiglitazone, a peroxisome proliferatoractivated receptor gamma ligand, in relation to nitric oxide显示文摘 | A. T. Gonon MD PhD A. Bulhak F. Labruto P.-O. Sj?quist J. Pernow | 2007 | Basic Research in Cardiology2007，，1： | 1 |
| 19 | PPAR-α activation protecta the type 2 diabetic myocardium against ischemia-reperfusion injury:involvement of the PI3-kinase/Akt and NO pathway显示文摘 | Bulhak AA Jung C Ostenson CG | 2009 | Am J Physiol Heart Circ Physiol2009，296，3： | 1 |
| 20 | Protection against myocardial ischaemia/reperfusion injury by PPAR–α activation is related to production of nitric oxide and endothelin–1显示文摘 | A. A. Bulhak P.-O. Sj?quist C.-B. Xu L. Edvinsson J. Pernow | 2006 | Basic Research in Cardiology2006，，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员